Publicaciones en colaboración con investigadores/as de Hospital General de Castellón (22)

2024

  1. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

    Revista Espanola de Cardiologia

2023

  1. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622

  2. Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study

    Frontiers in Cardiovascular Medicine, Vol. 10

2022

  1. Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure

    European Journal of Heart Failure, Vol. 24, Núm. 11, pp. 2108-2117

2020

  1. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470

  2. Sex-differential effect of frailty on long-term mortality in elderly patients after an acute coronary syndrome

    International Journal of Cardiology, Vol. 302, pp. 30-33

  3. The emerging role of carbohydrate antigen 125 in heart failure

    Biomarkers in Medicine, Vol. 14, Núm. 4, pp. 249-252

  4. Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective Registry

    JACC: Cardiovascular Imaging, Vol. 13, Núm. 8, pp. 1674-1686

2019

  1. Early Sacubitril/Valsartan-driven Benefit on Exercise Capacity in Heart Failure With Reduced Ejection Fraction: A Pilot Study

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 167-169

  2. Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Trial

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 288-297

  3. Sex differences on peak oxygen uptake in heart failure

    ESC Heart Failure, Vol. 6, Núm. 5, pp. 921-926

2018

  1. Clinical utility of cardiopulmonary exercise testing in patients with heart failure with preserved ejection fraction

    European Journal of Heart Failure

  2. Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study

    Clinical Cardiology, Vol. 41, Núm. 4, pp. 476-480

  3. Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction

    ESC Heart Failure, Vol. 5, Núm. 4, pp. 579-585

  4. Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 250-256

  5. Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study

    International Journal of Cardiology, Vol. 252, pp. 136-139

2017

  1. Inspiratory Muscle Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

    Journal of Cardiac Failure, Vol. 23, Núm. 6, pp. 480-484

2015

  1. Endo-Epicardial Versus Only-Endocardial Ablation as a First Line Strategy for the Treatment of Ventricular Tachycardia in Patients with Ischemic Heart Disease

    Circulation: Arrhythmia and Electrophysiology, Vol. 8, Núm. 4, pp. 882-889

2014

  1. Effects of inspiratory muscle training in patients with heart failure with preserved ejection fraction

    European Journal of Preventive Cardiology, Vol. 21, Núm. 12, pp. 1465-1473

  2. Valor pronóstico de la isquemia miocárdica y la necrosis en pacientes con la función ventricular izquierda deprimida: un registro multicéntrico con resonancia magnética cardiaca de estrés

    Revista Espanola de Cardiologia, Vol. 67, Núm. 9, pp. 693-700